Institut Bergonié
Clinical trials sponsored by Institut Bergonié, explained in plain language.
-
Can a geriatric team help older cancer patients live better and longer?
Disease control CompletedThis study tested whether adding a specialized geriatric care team to standard cancer treatment could help older patients. It involved 792 patients aged 70 and older with various advanced cancers. The goal was to see if this coordinated care approach improved survival and quality…
Phase: NA • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Precision radiation boosts fight against rare abdominal cancer
Disease control CompletedThis study tested a new approach for treating a rare abdominal cancer called retroperitoneal liposarcoma. It combined a precise, high-dose form of radiation (helical tomotherapy) with surgery, aiming to better control the cancer and prevent it from coming back. The trial enrolled…
Phase: NA • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Early trial tests Two-Drug attack on tough cancers
Disease control CompletedThis early-stage study tested whether combining two drugs—trabectedin and durvalumab—is safe and shows promise for treating advanced soft-tissue sarcoma and ovarian cancer. The trial involved 40 patients whose cancers had progressed despite previous treatments. Researchers aimed …
Phase: PHASE1 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug combo tested for Tough-to-Treat sarcoma
Disease control CompletedThis study tested whether combining two existing cancer drugs (trabectedin and cyclophosphamide) could help control advanced soft-tissue sarcoma in patients whose previous treatments had stopped working. The first phase determined the safest dose, and the second phase checked if …
Phase: PHASE1, PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Scientists test new Drug-Radiation combo in fight against tough sarcomas
Disease control CompletedThis early-stage study tested whether adding a drug called olaparib to standard radiation therapy is safe and might help control advanced soft-tissue sarcomas that cannot be surgically removed. It involved 41 adults with these difficult-to-treat tumors. The main goal was to find …
Phase: PHASE1 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Scientists test new drug duo to fight tough cancers
Disease control CompletedThis study tested whether combining an immunotherapy drug (durvalumab) with an epigenetic drug (tazemetostat) could help control advanced solid tumors. It enrolled 164 adults with specific advanced cancers, including pancreatic, colorectal, and soft-tissue sarcoma, who had run ou…
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Heat zaps breast cancer in patients who Can't have surgery
Disease control CompletedThis study tested a non-surgical treatment for older adults with breast cancer who could not or did not want to have an operation. Doctors used ultrasound to guide a needle that heats and destroys the tumor, combined with hormone-blocking pills. The goal was to see if this approa…
Phase: NA • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New surgical timing could slash leak risk in rectal cancer patients
Disease control CompletedThis study tested whether waiting to reconnect the bowel after rectal cancer surgery is safer than doing it immediately. It involved 124 patients with medium or lower rectal cancer. The goal was to see if the delayed method reduces serious leaks, cuts down on the need for tempora…
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New combo therapy fights rare, tough cancers
Disease control CompletedThis study tested whether combining an immunotherapy drug (MK3475) with a low-dose chemotherapy (cyclophosphamide) could help control advanced sarcomas, a group of rare cancers. It involved 129 adults whose cancer had progressed despite prior treatments. The main goal was to see …
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New pill tested to halt growth of rare, aggressive tumors
Disease control CompletedThis study tested whether a daily pill called pazopanib could control the growth of progressive desmoid tumors, which are aggressive non-cancerous growths. It compared the pill against a standard chemotherapy combination (methotrexate and vinblastine) in 72 adults whose tumors we…
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Mar 16, 2026 15:27 UTC
-
Study aims to spare breast cancer patients unnecessary surgery
Diagnosis CompletedThis study looked at whether checking just the first few lymph nodes (sentinel node biopsy) during a mastectomy for a type of early breast cancer called DCIS could help patients. The goal was to see if this approach could prevent the need for a more extensive lymph node removal s…
Sponsor: Institut Bergonié • Aim: Diagnosis
Last updated Mar 27, 2026 12:41 UTC
-
Blood test trial aims to speed up lung cancer treatment decisions
Diagnosis CompletedThis study tested whether combining a blood test (liquid biopsy) with traditional tissue analysis could better identify specific genetic changes in patients with advanced non-small cell lung cancer. Researchers enrolled 581 newly diagnosed patients to compare how well each method…
Phase: NA • Sponsor: Institut Bergonié • Aim: Diagnosis
Last updated Mar 27, 2026 12:39 UTC
-
New scan could sharpen bladder cancer detection
Diagnosis CompletedThis study looked back at medical records to see if a specialized imaging test called a PET CT scan is better than the standard CT scan at finding out if advanced bladder cancer has spread. Researchers analyzed data from 130 patients to see if the PET CT could more accurately det…
Sponsor: Institut Bergonié • Aim: Diagnosis
Last updated Mar 25, 2026 14:08 UTC
-
New biopsy test aims to spare cancer patients from invasive surgery
Diagnosis CompletedThis study tested a less invasive biopsy method for diagnosing suspicious lymph nodes found on PET scans in cancer patients. Researchers wanted to see if a guided needle biopsy, done through a tube in the throat, could accurately diagnose these lymph nodes. If successful, this me…
Phase: NA • Sponsor: Institut Bergonié • Aim: Diagnosis
Last updated Mar 25, 2026 14:07 UTC
-
New imaging technique helps surgeons spot hidden liver tumors
Diagnosis CompletedThis study tested whether adding a special contrast dye to ultrasound imaging during surgery helps surgeons see liver tumors more clearly. It involved 68 patients with colorectal cancer that had spread to the liver. The goal was to see if this enhanced imaging led surgeons to cha…
Phase: NA • Sponsor: Institut Bergonié • Aim: Diagnosis
Last updated Mar 24, 2026 12:02 UTC
-
New scan aims to spot hidden breast cancer clues
Diagnosis CompletedThis study tested whether an MRI scan could help find breast cancer in women who have suspicious nipple discharge, but whose standard mammograms and ultrasounds look normal. It involved 70 women to see if MRI could accurately rule out cancer when it appears normal. The goal was t…
Sponsor: Institut Bergonié • Aim: Diagnosis
Last updated Mar 24, 2026 12:02 UTC
-
Smartwatch study aims to ease life for distant cancer patients
Symptom relief CompletedThis study tested whether using technology could help improve care for people with advanced breast cancer who live far from their treatment center. Fifteen patients used tablets to report symptoms weekly and wore smartwatches that tracked their activity and sleep. Researchers wan…
Sponsor: Institut Bergonié • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC
-
Laughing gas tested to ease Post-Surgery pain for spine patients
Symptom relief CompletedThis study tested whether giving nitrous oxide (laughing gas) during surgery could help reduce pain and the need for strong painkillers afterward. It focused on patients who were already taking long-term opioid medication and were having a vertebroplasty procedure to treat spine …
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC
-
Ketamine during surgery could cut Post-Op pain and morphine need
Symptom relief CompletedThis study tested whether giving ketamine during and after breast cancer surgery helps reduce pain and the need for morphine in recovery. It involved 230 women undergoing mastectomy or lumpectomy. Researchers compared pain levels and morphine use in the first 48 hours after surge…
Phase: PHASE3 • Sponsor: Institut Bergonié • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
New approach tested to ease severe pain after lung cancer surgery
Symptom relief CompletedThis study tested whether a local anesthetic (ropivacaine) injected into the chest cavity during surgery could reduce severe pain after lung cancer operations. It involved 90 adults undergoing chest surgery for cancer. Researchers compared pain levels and measured how much of the…
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Symptom relief
Last updated Mar 30, 2026 14:31 UTC
-
Researchers map rare cancer gene to guide future treatments
Knowledge-focused CompletedThis study aimed to understand how often a specific genetic change called an NTRK fusion occurs in people with advanced solid tumors. Researchers analyzed tumor samples from over 3,800 patients who had already received cancer treatment. The goal was to gather information to help …
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Sleep tests reveal hidden side effect of cancer surgery
Knowledge-focused CompletedThis study aimed to better understand how common erectile dysfunction is after rectal cancer treatment. Researchers used special sleep monitoring devices to measure nighttime erections in 12 men who had surgery for early-stage rectal cancer. The goal was to get objective data abo…
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Hidden heart risk? study probes anesthesia danger for breast cancer survivors
Knowledge-focused CompletedThis study aimed to understand if general anesthesia during breast cancer surgery puts extra stress on the heart for patients who previously received a specific type of chemotherapy called anthracyclines. Researchers measured a blood marker (BNP) linked to heart strain before, du…
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Doctors test a script for delivering the hardest news
Knowledge-focused CompletedThis study tested a new, standardized interview guide for doctors to use when telling a patient they have cancer. Researchers worked with 252 adult cancer patients and their caregivers to see if the guide was reliable and easy for nurses to use. The goal was to create a better, m…
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
Researchers dig into why some elderly cancer patients get worse care
Knowledge-focused CompletedThis study looked back at data to understand what factors affect cancer care for people aged 65 and older. Researchers analyzed health records from 450 older adults in France diagnosed with cancer between 2005 and 2014. The goal was to see how things like age, income, and overall…
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC
-
Researchers test new way to track cancer treatment effectiveness
Knowledge-focused CompletedThis study investigated whether measuring 'time until next treatment or death' is a good way to track how well cancer treatments work, compared to the traditional measure of overall survival. Researchers looked at 631 patients with advanced melanoma who were receiving immunothera…
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC
-
Doctors test MRI as crystal ball for breast cancer treatment
Knowledge-focused CompletedThis small pilot study tested whether MRI scans could reliably measure how well breast cancer responds to chemotherapy early in treatment. Researchers enrolled 16 women with breast cancer who were scheduled to receive chemotherapy before surgery. The goal was to see if MRI measur…
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC
-
Scientists search for genetic clues to improve cancer treatment
Knowledge-focused CompletedThis study aimed to understand if a person's genetics can predict how well the drug cetuximab works for treating advanced head and neck cancers. Researchers collected blood samples from 121 patients with recurrent or metastatic cancer to analyze specific genes. The goal was to fi…
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC
-
Researchers map the Real-Life battle against spreading bone cancers
Knowledge-focused CompletedThis study looked back at the medical records of 545 patients to understand how doctors treat metastatic bone tumors in real-world settings. It focused on patients aged 12 and older diagnosed with specific bone cancers between 2008 and 2018. The goal was to describe the treatment…
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC
-
Researchers develop new math to design better medical studies
Knowledge-focused CompletedThis study aimed to create a better statistical method for planning future clinical trials. It focused on how to calculate the right number of participants needed when the people in the study have different risks or might respond differently to a treatment. The goal was to improv…
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:27 UTC
-
Can burning tumors train the body to fight cancer?
Knowledge-focused CompletedThis study aimed to understand how using heat to destroy lung tumors from colorectal cancer affects the body's immune system. Researchers enrolled 20 patients to measure immune cell activity before and after the heat treatment procedure. The goal was to learn if destroying tumors…
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC
-
Massive data dive seeks clues to improve sarcoma survival
Knowledge-focused CompletedThis study looked back at the medical records of over 2,000 adults with advanced soft tissue sarcoma to understand what treatments they received in real-world clinics and how long they lived. Researchers analyzed patterns of care, including chemotherapy and off-label drug use, to…
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:37 UTC
-
Experts redefine success in cancer trials for seniors
Knowledge-focused CompletedThis project aimed to create guidelines for future cancer trials involving older adults. A panel of experts reviewed what outcomes, like maintaining independence and quality of life, are most important to measure for this group, beyond just tracking tumor growth. The goal is to h…
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC
-
Scientists hunt for clues to match sarcoma patients with treatment
Knowledge-focused CompletedThis study aimed to find biological markers that could predict which patients with advanced soft-tissue sarcoma would respond well to the drug trabectedin. Researchers collected tumor and blood samples from 29 adult patients before, during, and after treatment to analyze their ge…
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC
-
Massive 20,000-Patient study seeks faster ways to measure cancer treatment success
Knowledge-focused CompletedThis study analyzed existing medical records from over 20,000 women with metastatic breast cancer in France. Researchers examined real-world survival data to find faster, reliable ways to measure if cancer treatments are working. The goal is to help future clinical trials get res…
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:48 UTC
-
Landmark study maps cancer care journey for 500 patients
Knowledge-focused CompletedThis study observed 492 adults in France with advanced gastrointestinal stromal tumor (GIST) cancer to understand how doctors treat this disease in real-world settings. Researchers looked back at patient records from 1990 to 2018 to map out the sequence of treatments used and mea…
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:25 UTC
-
Hospital staff blood study reveals hidden COVID-19 infections and worker anxiety
Knowledge-focused CompletedThis study aimed to understand how many hospital workers at a cancer center had been infected with COVID-19 by checking their blood for antibodies. Researchers followed 526 staff members for one year, testing their blood at the start, 3 months, and 12 months to see if they develo…
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Mar 09, 2026 14:22 UTC